BA
Bhalla Amit Director
OFFICER M
US US · SEC (Form 4)
Browse the detailed record of transactions filed by Bhalla Amit, Director. Insider active across 1 companies, notably Navidea Biopharmaceuticals, INC.. In total, 16 disclosures have been published. The latest transaction was disclosed on 31 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations 16 total
02,500 shares 0
Common Stock
SEC:0001437749-22-014039:0 · 31 May 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-010721:0 · 30 Apr 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-007853:0 · 31 Mar 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-004841:0 · 28 Feb 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-002106 · 31 Jan 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-002106:0 · 31 Jan 2022
02,500 shares 0
Common Stock
SEC:0001437749-22-000316 · 31 Dec 2021
02,500 shares 0
Common Stock
SEC:0001437749-22-000316:0 · 31 Dec 2021
€26 30,000 shares @ €0.0009 100.0% of flow
Common Stock
SEC:0001437749-21-027690 · 15 Nov 2021
€26 30,000 shares @ €0.0009 48.1% of flow
Common Stock
SEC:0001437749-21-027690:0 · 15 Nov 2021
04,286 shares 0
Common Stock
SEC:0001437749-21-023087 · 30 Sept 2021
04,286 shares 0
Common Stock
SEC:0001437749-21-023087:0 · 30 Sept 2021
02,409 shares 0
Common Stock
SEC:0001437749-21-016594 · 30 Jun 2021
02,409 shares 0
Common Stock
SEC:0001437749-21-016594:0 · 30 Jun 2021
2,500 shares
Common Stock
SEC:0001437749-21-011198 · 4 May 2021
€2 2,500 shares @ €0.0008 3.8% of flow
Common Stock
SEC:0001437749-21-011198:0 · 4 May 2021
About Bhalla Amit Amit Bhalla is a director at NAVIDEA BIOPHARMACEUTICALS, INC.